The use of Fluidda’s FRI technology in the combat against COPD. The exact prevalence of COPD worldwide is largely unknown, but estimates have varied from 7-19%. The Burden of Obstructive Lung Disease (BOLD) study... View Article
Delta Hospital uses new imaging technology for better triage and optimal treatment of COVID-19 patients. Due to the very large number of Corona patients who now report daily for hospitalization,... View Article
FRI assessment of a fixed Triple Therapy (Bud/Gly/FF) and a fixed Dual Therapy (Gly/FF) in patients with COPD In a study presented as a poster at the virtual Chest conference, FRI was used... View Article
Fluidda’s Online Site Training Course For Clinical Research Sites goes ” LIVE” For years Fluidda educates pulmonologists and CT-scanning personnel “on site” how to perform HRCT-scans that can be used in Clinical Trials... View Article
Time for a paradigm shift in lung function research? The golden age of pulmonary function testing began in the 1920s, driven by the increasing prevalence of occupational lung disease and resulting interest... View Article
Fluidda’s FRI-activities are at “Full Speed” during this COVID-19 pandemic The COVID-19 crisis has had a tremendous impact on the initiation and progression of clinical research around the world and... View Article
A Public-private consortium P4O2 (Precision Medicine for more Oxygen) investigates risk factors for developing lung damage and chronic complaints after COVID-19. Many patients who have had COVID-19 continue to have... View Article
FRI used to assess short-term effects of Orkambi on lung function in patients with CF homozygous for F508de The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator Orkambi (lumacaftor-ivacaftor) has shown modest benefits... View Article
On July 1, Chiesi and Fluidda organized an international webinar for pneumologists and other health professionals, discussing the use of Functional Respiratory Imaging during the covid-19 pandemic in three different... View Article
Lung Deposition of Two Bronchodilators in Subjects with COPD When Administered via Standard Jet Nebulizer or HandiHaler® Using FRI. During the ERS Congress 2020, a poster was presented comparing lung deposition of... View Article